ロード中...
Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Coronary Heart Disease (PROSPECTIVE)
Aims: Although intensive statin therapy reduced cardiovascular risks, cardiovascular events have not been completely prevented. Probucol is a potent antioxidant and reduces tendon xanthomas in familial hypercholesterolemia patients despite reduction of high-density lipoprotein (HDL)-cholesterol (HDL...
保存先:
| 出版年: | J Atheroscler Thromb |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Japan Atherosclerosis Society
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7957028/ https://ncbi.nlm.nih.gov/pubmed/32336695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.55327 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|